|
US20020019527A1
(en)
|
2000-04-27 |
2002-02-14 |
Wei-Bo Wang |
Substituted phenyl farnesyltransferase inhibitors
|
|
JP2004509064A
(ja)
|
2000-04-27 |
2004-03-25 |
アボット・ラボラトリーズ |
置換フェニルファルネシルトランスフェラーゼ阻害剤
|
|
AU2001273040A1
(en)
|
2000-06-27 |
2002-01-08 |
Du Pont Pharmaceuticals Company |
Factor xa inhibitors
|
|
WO2002049632A1
(en)
|
2000-12-18 |
2002-06-27 |
Institute Of Medicinal Molecular Design. Inc. |
Inhibitors against the production and release of inflammatory cytokines
|
|
DE10064823A1
(de)
|
2000-12-22 |
2002-06-27 |
Knoll Ag |
Integrinrezeptorliganden
|
|
US6806265B2
(en)
|
2002-05-16 |
2004-10-19 |
Boehringer Ingelheim International Gmbh |
Non-nucleoside reverse transcriptase inhibitors
|
|
EP1556035A4
(en)
*
|
2002-09-20 |
2006-09-13 |
Genelabs Tech Inc |
NEW AROMATIC COMPOUNDS WITH ANTIMYCOTIC OR ANTIBACTERIAL EFFECT
|
|
CA2531418A1
(en)
|
2003-07-08 |
2005-01-20 |
Novartis Ag |
Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
|
|
US20080220497A1
(en)
|
2003-12-24 |
2008-09-11 |
Flynn Daniel L |
Modulation of protein functionalities
|
|
CN1810777B
(zh)
*
|
2005-01-24 |
2010-09-29 |
上海东浩医药生物企业有限公司 |
一类治疗或预防细菌感染的化合物及其制备方法和用途
|
|
JP2009533315A
(ja)
*
|
2006-04-10 |
2009-09-17 |
ランバクシー ラボラトリーズ リミテッド |
抗菌剤
|
|
US8039502B2
(en)
*
|
2007-07-24 |
2011-10-18 |
The Ohio State University Research Foundation |
Anti-infective agents against intracellular pathogens
|
|
KR20100067102A
(ko)
|
2007-09-04 |
2010-06-18 |
바이올리폭스 에이비 |
염증의 치료에 유용한 비스-방향족 화합물
|
|
AU2008321142A1
(en)
|
2007-11-13 |
2009-05-22 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
CN102036985A
(zh)
|
2007-11-13 |
2011-04-27 |
沃泰克斯药物股份有限公司 |
用于治疗疼痛的作为离子通道调节剂的4(-3-(-2-(苯基)吗啉代)-2-氧代吡咯烷-1-基)-n-(噻唑-2-基)苯磺酰胺衍生物和相关化合物
|
|
JP5038509B2
(ja)
|
2008-01-18 |
2012-10-03 |
メルク・シャープ・エンド・ドーム・コーポレイション |
β−ラクタマーゼ阻害剤
|
|
WO2009094224A1
(en)
|
2008-01-25 |
2009-07-30 |
Millennium Pharmaceuticals, Inc. |
Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
|
|
WO2009118596A2
(en)
|
2008-03-26 |
2009-10-01 |
Glenmark Pharmaceuticals, S. A. |
Phthalimide derivatives as trpa1 modulators
|
|
EA201001847A1
(ru)
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
|
US20110294853A1
(en)
|
2008-09-12 |
2011-12-01 |
Benjamin Pelcman |
Bis Aromatic Compounds for Use in the Treatment of Inflammation
|
|
PT2385763T
(pt)
|
2009-01-12 |
2018-07-13 |
Aerpio Therapeutics Inc |
Métodos para tratar o síndrome de extravasamento vascular
|
|
US8580795B2
(en)
|
2009-01-22 |
2013-11-12 |
Orchid Chemicals & Pharmaceuticals Limited |
Heterocyclic compounds as phosphodiesterase inhibitors
|
|
BRPI1006897A2
(pt)
|
2009-07-06 |
2015-09-08 |
Akebia Therapeutics Inc |
compostos, composições e métodos de prevenção da metástase de células cancerosas.
|
|
WO2011084882A2
(en)
|
2010-01-05 |
2011-07-14 |
Contrafect Corporation |
Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
|
|
WO2011121505A1
(en)
|
2010-03-29 |
2011-10-06 |
Piramal Life Sciences Limited |
Cytokine inhibitors
|
|
US8829191B2
(en)
|
2011-06-17 |
2014-09-09 |
Melanie Simone Ronsheim |
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
|
|
BR112014003476A2
(pt)
|
2011-09-13 |
2017-03-01 |
Wockhardt Ltd |
compostos contendo nitrogênio e seu uso
|
|
HK1203763A1
(en)
*
|
2012-01-18 |
2015-11-06 |
Cellceutix Corporation |
Compounds and methods for treating candidiasis and aspergillus infections
|
|
WO2013123444A1
(en)
|
2012-02-17 |
2013-08-22 |
Amgen Inc. |
Sulfonyl compounds that interact with glucokinase regulatory protein
|
|
US9566310B2
(en)
|
2012-09-10 |
2017-02-14 |
Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno |
Methods of treating muscular dystrophy
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
UA111925C2
(uk)
|
2012-12-11 |
2016-06-24 |
Федора Фармасьютікалз Інк. |
БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
|
|
EP2968273A4
(en)
|
2013-03-15 |
2016-08-31 |
Univ Nevada |
METHOD FOR THE TREATMENT OF MUSCLE DYSTROPHIES
|
|
WO2014179784A2
(en)
*
|
2013-05-03 |
2014-11-06 |
Microbiotix, Inc. |
Antimicrobial potentiators
|
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
|
WO2014190199A1
(en)
|
2013-05-24 |
2014-11-27 |
The California Institute For Biomedical Research |
Compounds for treatment of drug resistant and persistent tuberculosis
|
|
GB201310542D0
(en)
*
|
2013-06-13 |
2013-07-31 |
Antabio Sas |
Compounds
|
|
CN105612159A
(zh)
|
2013-10-08 |
2016-05-25 |
明治制果药业株式会社 |
二氮杂二环辛烷衍生物的结晶及其制备方法
|
|
WO2015110885A1
(en)
|
2014-01-21 |
2015-07-30 |
Wockhardt Limited |
A process for preparation of (2s,5r)-6-sulphooxy-7-oxo-2-[((3r)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane
|
|
EP3102578A1
(en)
|
2014-02-03 |
2016-12-14 |
Wockhardt Limited |
A process for preparation of (2s, 5r)-1,6-diaza-bicyclo [3.2.1]octane-2-carbonitrile-7-oxo-6-(sulfooxy)-mono sodium salt
|
|
ES2748029T3
(es)
|
2014-03-13 |
2020-03-12 |
Univ Indiana Res & Tech Corp |
Moduladores alostéricos de proteína núcleo de hepatitis B
|
|
GB2533136A
(en)
*
|
2014-12-11 |
2016-06-15 |
Antabio Sas |
Compounds
|